Qiaojun He

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Chemotherapy Induced

Childhood Cancer

Top Venues

British journal of pharmacology

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Yan, Xiangliang Huang, Jiangxin Xu, Ying Zhang, Jiajia Chen, Zhifei Xu, Hui Li, Zeng Wang, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yourong Zhou, Yiming Yin, Jiangxin Xu, Jiangxin Xu, Bo Yang, Qiaojun He, Peihua Luo, Hao Yan, Xiaochun Yang
An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer. Expert opinion on pharmacotherapy (2023)
Wei Wang, Yingqian Chen, Aixiao Xu, Minyi Cai, Ji Cao, Hong Zhu, Bo Yang, Xuejing Shao, Meidan Ying, Qiaojun He
Protein phase separation: A novel therapy for cancer? British journal of pharmacology 177 (22) (2020)
Xiaomeng Gao, Li Jiang, Yanling Gong, Xiaobing Chen, Meidan Ying, Hong Zhu, Qiaojun He, Bo Yang, Ji Cao
Stress granule: A promising target for cancer treatment. British journal of pharmacology 176 (23) (2019)
Li Jiang, Rong Dong, Meidan Ying, Qiaojun He, Ji Cao, Bo Yang
Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics. British journal of pharmacology 175 (23) (2018)